Successful treatment of non-midline primary malignant germ cell tumors with yolk sac components in neonates: report of 2 cases.
alpha-fetoprotein
chemotherapy
mixed germ cell tumor
nongerminomatous germ cell tumor
oncology
yolk sac tumor
Journal
Journal of neurosurgery. Pediatrics
ISSN: 1933-0715
Titre abrégé: J Neurosurg Pediatr
Pays: United States
ID NLM: 101463759
Informations de publication
Date de publication:
30 Oct 2020
30 Oct 2020
Historique:
received:
04
12
2019
accepted:
03
06
2020
pubmed:
31
10
2020
medline:
16
2
2022
entrez:
30
10
2020
Statut:
epublish
Résumé
Here, the authors present 2 cases of nongerminomatous germ cell tumor (NGGCT): a neonate with a mixed malignant germ cell tumor, 5% yolk sac tumor (YST) and 95% immature teratoma components, originating from the right mesial temporal lobe; and a 2-month-old infant with a pure YST originating from the left middle cranial fossa. These tumors with yolk sac components, which are thought to have a poor prognosis, were successfully treated with complete tumor resection alone and subtotal tumor resection with chemotherapy, respectively. Event-free survival exceeds 5 years for each patient even though neither received radiotherapy. The authors highlight the role of radical surgery and the successful treatment of neonatal YST with aggressive resection (and chemotherapy in 1 case) while avoiding radiation therapy. They also report the very rare non-midline location of these neonatal NGGCTs and emphasize the importance of considering YSTs and mixed NGGCTs with YST components in the differential diagnosis of non-midline hemispheric or skull base tumors in newborns.
Identifiants
pubmed: 33126205
doi: 10.3171/2020.6.PEDS19719
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM